3'-Azido-2',3'-dideoxycytidine(CAS: 84472-89-9)

3'-Azido-2',3'-dideoxycytidine (CAS: 84472-89-9) falls under the regulatory framework of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous chemicals. It is also classified under REACH regulations in the European Union, which require detailed safety data sheets (SDS) for handling and disposal. In the United States, the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) may impose additional requirements related to research and manufacturing processes.

There are several alternatives to 3'-Azido-2',3'-dideoxycytidine (CAS: 84472-89-9) in synthesis, such as other azido-containing nucleosides like 3'-Azido-2',3'-dideoxyinosine and 3'-Azido-2',3'-dideoxythymidine. Common alternative reagents include nucleoside triphosphates and their analogs, which can serve as precursors in the synthesis of nucleoside derivatives.

The market and research trends for 3'-Azido-2',3'-dideoxycytidine (CAS: 84472-89-9) are closely linked to its applications in antiretroviral therapy and HIV research. Recent studies are focusing on its potential as a component in novel antiretroviral drugs and as a tool for gene editing and gene therapy. Market trends indicate increasing demand for this compound due to advancements in AIDS treatment and gene modification technologies.

Waste containing 3'-Azido-2',3'-dideoxycytidine (CAS: 84472-89-9) should be managed according to local and international hazardous waste regulations. Proper disposal methods include collection in dedicated containers, followed by incineration or professional waste disposal by certified companies. Environmental protection precautions include minimizing spills and ensuring all waste is neutralized before disposal to prevent contamination of the environment and public health.